Cargando…

Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9

The CRISPR/Cas9 system is a powerful genome editing tool for the production of genetically modified animals. To produce mutant mice, chimeric single-guide RNA (sgRNA) is cloned in a plasmid vector and a mixture of sgRNA and Cas9 are microinjected into the fertilized eggs. An issue associated with ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Terao, Miho, Tamano, Moe, Hara, Satoshi, Kato, Tomoko, Kinoshita, Masato, Takada, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Association for Laboratory Animal Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976241/
https://www.ncbi.nlm.nih.gov/pubmed/26972821
http://dx.doi.org/10.1538/expanim.15-0116
_version_ 1782446836285440000
author Terao, Miho
Tamano, Moe
Hara, Satoshi
Kato, Tomoko
Kinoshita, Masato
Takada, Shuji
author_facet Terao, Miho
Tamano, Moe
Hara, Satoshi
Kato, Tomoko
Kinoshita, Masato
Takada, Shuji
author_sort Terao, Miho
collection PubMed
description The CRISPR/Cas9 system is a powerful genome editing tool for the production of genetically modified animals. To produce mutant mice, chimeric single-guide RNA (sgRNA) is cloned in a plasmid vector and a mixture of sgRNA and Cas9 are microinjected into the fertilized eggs. An issue associated with gene manipulation using the CRISPR/Cas9 system is that there can be off-target effects. To simplify the production of mutant mice with low risks of off-target effects caused by the CRISPR/Cas9 system, we demonstrated that genetically modified mice can be efficiently obtained using chemically synthesized CRISPR RNA (crRNA), trans-activating crRNA (tracrRNA), and modified Cas9s, such as the nickase version and FokI-fused catalytically inactive Cas9, by microinjection into fertilized eggs. Using this method, it is no longer necessary to clone sgRNA into a plasmid vector, and this enables high-throughput production of mutant mice.
format Online
Article
Text
id pubmed-4976241
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Japanese Association for Laboratory Animal Science
record_format MEDLINE/PubMed
spelling pubmed-49762412016-08-09 Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9 Terao, Miho Tamano, Moe Hara, Satoshi Kato, Tomoko Kinoshita, Masato Takada, Shuji Exp Anim Original The CRISPR/Cas9 system is a powerful genome editing tool for the production of genetically modified animals. To produce mutant mice, chimeric single-guide RNA (sgRNA) is cloned in a plasmid vector and a mixture of sgRNA and Cas9 are microinjected into the fertilized eggs. An issue associated with gene manipulation using the CRISPR/Cas9 system is that there can be off-target effects. To simplify the production of mutant mice with low risks of off-target effects caused by the CRISPR/Cas9 system, we demonstrated that genetically modified mice can be efficiently obtained using chemically synthesized CRISPR RNA (crRNA), trans-activating crRNA (tracrRNA), and modified Cas9s, such as the nickase version and FokI-fused catalytically inactive Cas9, by microinjection into fertilized eggs. Using this method, it is no longer necessary to clone sgRNA into a plasmid vector, and this enables high-throughput production of mutant mice. Japanese Association for Laboratory Animal Science 2016-03-14 2016 /pmc/articles/PMC4976241/ /pubmed/26972821 http://dx.doi.org/10.1538/expanim.15-0116 Text en ©2016 Japanese Association for Laboratory Animal Science http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License.
spellingShingle Original
Terao, Miho
Tamano, Moe
Hara, Satoshi
Kato, Tomoko
Kinoshita, Masato
Takada, Shuji
Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9
title Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9
title_full Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9
title_fullStr Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9
title_full_unstemmed Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9
title_short Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9
title_sort utilization of the crispr/cas9 system for the efficient production of mutant mice using crrna/tracrrna with cas9 nickase and foki-dcas9
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976241/
https://www.ncbi.nlm.nih.gov/pubmed/26972821
http://dx.doi.org/10.1538/expanim.15-0116
work_keys_str_mv AT teraomiho utilizationofthecrisprcas9systemfortheefficientproductionofmutantmiceusingcrrnatracrrnawithcas9nickaseandfokidcas9
AT tamanomoe utilizationofthecrisprcas9systemfortheefficientproductionofmutantmiceusingcrrnatracrrnawithcas9nickaseandfokidcas9
AT harasatoshi utilizationofthecrisprcas9systemfortheefficientproductionofmutantmiceusingcrrnatracrrnawithcas9nickaseandfokidcas9
AT katotomoko utilizationofthecrisprcas9systemfortheefficientproductionofmutantmiceusingcrrnatracrrnawithcas9nickaseandfokidcas9
AT kinoshitamasato utilizationofthecrisprcas9systemfortheefficientproductionofmutantmiceusingcrrnatracrrnawithcas9nickaseandfokidcas9
AT takadashuji utilizationofthecrisprcas9systemfortheefficientproductionofmutantmiceusingcrrnatracrrnawithcas9nickaseandfokidcas9